CLINICAL_TRIALS
research
· 2026-04-21
Clinical Trial Update: Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF [Phase 3]
Summary
Phase 3 confirmatory trial of HEC585 tablets for idiopathic pulmonary fibrosis is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 3 | Status: RECRUITING